Stockholders Approve 18 Million Share Increase for Equity Incentive Plan
MARA has more than doubled off its 52-week low of $6.66.
Summary
MARA Holdings' stockholders approved an increase of 18 million shares for the company's equity incentive plan, authorizing potential future dilution for employee compensation.
Key Events · Corporate Governance and Compliance · MARA
-
Equity Incentive Plan Expanded
Stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing the authorized shares for issuance by 18,000,000. This follows the DEFA14A filing on April 30, 2026, which sought shareholder approval for this increase.
-
Potential Dilution
This authorization represents a potential dilution of approximately 4.72% of the company's current market capitalization if all authorized shares were issued.
-
Annual Meeting Results
The company also reported the election of Class III directors, ratification of PricewaterhouseCoopers LLP as its independent accounting firm, and advisory approval of executive compensation at its 2026 annual meeting.
Analysis · MARA · Crypto Assets
The approval of an additional 18 million shares for the equity incentive plan represents a significant potential dilution of approximately 4.72% of the company's current market capitalization. While common for employee compensation, this authorization adds to the potential share overhang, especially following recent substantial net losses and a strategic pivot towards AI and HPC infrastructure.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 29.6% of the 1721 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.34%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MARA was trading at $14.84 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $6.66 to $23.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.